These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Pathological features of Kawasaki disease (mucocutaneous lymph node syndrome). Landing BH, Larson EJ. Am J Cardiovasc Pathol; 1987; 1(2):218-29. PubMed ID: 3333141 [Abstract] [Full Text] [Related]
6. Immunopathology of murine lupus-overview, SL/Ni and MRL/Mp-lpr/lpr-. Kyogoku M, Nose M, Sawai T, Miyazawa M, Tachiwaki O, Kawashima M. Prog Clin Biol Res; 1987; 229():95-130. PubMed ID: 3601997 [Abstract] [Full Text] [Related]
8. Intravenous immunoglobulin and salicylate differentially modulate pathogenic processes leading to vascular damage in a model of Kawasaki disease. Lau AC, Duong TT, Ito S, Yeung RS. Arthritis Rheum; 2009 Jul; 60(7):2131-41. PubMed ID: 19565485 [Abstract] [Full Text] [Related]
14. [Youthful sudden cardiac death and the Kawasaki syndrome. An anatomopathological case report]. Nappo A, Rossi L, Matturri L. Minerva Cardioangiol; 1996 Mar; 44(3):127-32. PubMed ID: 8767612 [Abstract] [Full Text] [Related]
15. Sudden death in an adolescent four years after recovery from mucocutaneous lymph node syndrome (Kawasaki disease). Quam JP, Edwards WD, Bambara JF, Luzier TL. J Forensic Sci; 1986 Jul; 31(3):1135-41. PubMed ID: 3734732 [Abstract] [Full Text] [Related]
16. Activated myeloid dendritic cells accumulate and co-localize with CD3+ T cells in coronary artery lesions in patients with Kawasaki disease. Yilmaz A, Rowley A, Schulte DJ, Doherty TM, Schröder NW, Fishbein MC, Kalelkar M, Cicha I, Schubert K, Daniel WG, Garlichs CD, Arditi M. Exp Mol Pathol; 2007 Aug; 83(1):93-103. PubMed ID: 17335804 [Abstract] [Full Text] [Related]